Budget 2025: Life-saving drugs to get cheaper. Who benefits and by how much?
Leading global drugmakers such as MSD Pharmaceuticals, Novartis, AstraZeneca, and Pfizer stand to benefit as it opens new opportunities to expand access to their medicines through PAPs.
THE CHOSUNILBO on MSN18m
Korea-U.S. joint fund to propel Korean biotech startups into U.S. market
Global asset manager GordonMD Global Investments and South Korea’s biotech-focused venture capital firm Partners Investment have joined forces to launch a co-managed fund for biotech investments. The ...